Novel Targeted Therapy for Low-Grade Lymphoid Malignancies in Older Adults by Dr. Krem
Dr. Krem discusses age-related and biological factors for low-grade lymphoma pathogenesis and outcomes. He then explains the mechanisms of action from low-grade lymphoma therapies. He finishes by applying recent efficacy and toxicity data to older patients with low-grade lymphoma.
- Watch the Video on YouTube
- Watch a CME Accredited Lecture
- Watch Dr. Krem's lecture on Chemotherapy
Maxwell M. Krem, M.D., P.h.D.
Dr. Maxwell Krem is a medical oncologist who sees patients with hematologic malignancies at James Graham Brown Cancer Center (JGBCC), University of Louisville School of Medicine. His primary specialty is bone marrow transplantation. Dr. Krem recalls an experience he had as a young person when his grandfather had cancer. “I saw a lack of bedside manner and a lack of sensitivity,” he says, adding “It really made a big impression on me... I knew I could do better so I’ve tried to develop a humanistic approach in my rapport with patients and their families. I try to be a source of support, whatever the outcome."
Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page.
Disclaimers
©2015 LouisvilleLectures.org
Audry Hawkins is back to discuss antimicrobial stewardship in pneumonia. She starts with comparing differences in guidelines and recent primary literature on empiric treatment of pneumonia. Hawkins then evaluates appropriate empiric step-down therapy and durations and after, discusses the nuances in guideline recommendations for pneumonia.